Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Join us on Tuesday 4 June for an exclusive drinks reception and panel event featuring some of the UK’s top former and current sports professionals living with type 1 diabetes.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Join the type 1 diabetes community and come together, raising awareness and vital funds for T1D.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > News & events > News > Gala Ball raises £125k for type 1 diabetes
JDRF’s first in-person annual Gala Ball since 2019 has raised £125,000 for type 1 diabetes research.
The Ball was hosted by JDRF Honorary Patron and Sky Sports presenter Adam Smith and attended by JDRF Ambassador, the Rt Hon Theresa May MP.
Mrs May said: “I was delighted to be part of JDRF’s fundraising night, to prevent, treat and cure type 1 diabetes. There is so much research progress and potential and as JDRF’s global research ambassador I am proud to see the impact in developing treatments and technologies to transform health and wellbeing for people living with type 1 diabetes.”
The 1920s themed event included a silent auction of generously donated items, including weekend getaways, theatre tickets and TV memorabilia. There was also a raffle for a pair of diamond earrings kindly donated by Odendaal Diamonds.
The event took place just before World Diabetes Day and highlighted our #WeAreOne campaign. Within five minutes of Adam screening our emotional supporter video, the guests raised an incredible £50k in a phenomenal pledge moment.
The money raised will fund JDRF’s programme of research to find cures and improve the lives of people living with type 1.
JDRF’s Chief Executive, Karen Addington, said: “The enthusiasm and generosity of the type 1 community for the JDRF global research programme at our London Ball last night was overwhelming. It was a pleasure to host such an inspiring group of supporters. I would also like to acknowledge Adam Smith, Sky Sports presenter and Honorary Patron of JDRF, for his superb performance as our MC for the evening.”
Novo Nordisk is a corporate sponsor of this event.
This study is the largest and most comprehensive to date examining human pancreas tissue for signs of viral infection in people with and without type 1 diabetes (T1D).
People living with type 1 diabetes (T1D) across the UK now have more choice in how to manage their condition, with the mylife CamAPS FX app now available on iPhones.
This charitable pledge by the Bukhman Foundation represents the UK’s largest philanthropic commitment towards funding research to accelerate new treatments and a cure for type 1 diabetes.
We have launched a new 10-year strategy aimed at driving significant advancements in type 1 diabetes (T1D) research, treatment, and care.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.
